Stockscreener 앱 받기
0.82
10.87%
-0.10
시간 외 거래:
.84
0.02
+2.44%
전일 마감가:
$0.92
열려 있는:
$0.91
하루 거래량:
375.30K
Relative Volume:
0.11
시가총액:
$15.29M
수익:
$174.80K
순이익/손실:
$-8.85M
주가수익비율:
-1.1906
EPS:
-0.6887
순현금흐름:
$-4.37M
1주 성능:
-14.64%
1개월 성능:
-24.07%
6개월 성능:
-28.70%
1년 성능:
-79.29%
1일 변동 폭
$0.8101
$0.91
1주일 범위
$0.8101
$1.01
52주 변동 폭
$0.702
$4.09
Nexalin Technology Inc Stock (NXL) Company Profile
명칭
Nexalin Technology Inc
전화
(832) 260-0222
주소
1776 YORKTOWN, HOUSTON
NXL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NXL
Nexalin Technology Inc
|
0.82 | 17.16M | 174.80K | -8.85M | -4.37M | -0.6887 |
|
ABT
Abbott Laboratories
|
128.47 | 218.16B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.19 | 137.24B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
355.31 | 135.41B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
98.57 | 128.03B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.38 | 48.21B | 5.88B | 1.34B | 799.60M | 2.3489 |
Nexalin Technology Inc 주식(NXL)의 최신 뉴스
What analysts say about Nexalin Technology Inc Equity Warrant stockEarnings Miss Alerts & Superior Capital Trading Plans - earlytimes.in
Nexalin Technology and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Daytona Beach News-Journal
Market Overview: Will Nexalin Technology Inc stock outperform value stocksTrade Entry Report & Low Risk Investment Opportunities - moha.gov.vn
Nexalin Technology Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
Nexalin Technology unveils new investor presentation on DIFS - MSN
Nexalin Technology Unveils New Investor Presentation on DIFS - TipRanks
Nexalin Technology, Inc. Unveils Advanced Neurostimulation Technology - TradingView — Track All Markets
Will Nexalin Technology Inc. Equity Warrant stock reach Wall Street targetsTreasury Yields & Real-Time Stock Entry Alerts - Newser
Nexalin advances Alzheimer’s device after FDA meeting By Investing.com - Investing.com South Africa
Nexalin Technology completes FDA Q-submission meeting for Gen-2 Sync - marketscreener.com
Nexalin advances Alzheimer’s device after FDA meeting - Investing.com
Nexalin Technology Completes FDA Q-Submission Meeting for Gen-2 SYNC™ Neurostimulation Console in Alzheimer’s Disease Program - Yahoo Finance
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on December 4 - markets.businessinsider.com
How Nexalin Technology Inc. stock trades before earnings2025 Trading Recap & Risk Controlled Stock Alerts - Newser
Nexalin Technology earnings missed by $0.01, revenue fell short of estimates - Investing.com Canada
Join Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on December 4 - 富途牛牛
Volume Summary: Is Nexalin Technology Inc. Equity Warrant stock supported by strong cash flows2025 Technical Patterns & Smart Swing Trading Alerts - BỘ NỘI VỤ
Investors in cash trouble should check out Nexalin Technology Inc (NXL) - Setenews
Nexalin Technology (NASDAQ:NXL) Rating Lowered to Sell at Wall Street Zen - Defense World
Nexalin Technology Inc. (NXL) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Is Nexalin Technology Inc. Equity Warrant stock near bottom after decline2025 Trade Ideas & Reliable Intraday Trade Plans - newser.com
Why hedge funds are buying Nexalin Technology Inc. stockEarnings Growth Report & Expert-Curated Trade Recommendations - newser.com
Price momentum metrics for Nexalin Technology Inc. explainedWeekly Market Report & Expert Curated Trade Setup Alerts - newser.com
Is Nexalin Technology Inc. Equity Warrant stock trading near support levelsEarnings Miss & Short-Term High Return Strategies - newser.com
Can Nexalin Technology Inc. stock withstand economic slowdown - newser.com
Trend analysis for Nexalin Technology Inc. this weekJuly 2025 Short Interest & AI Optimized Trading Strategy Guides - newser.com
Risk vs reward if holding onto Nexalin Technology Inc.Buy Signal & High Accuracy Buy Signal Tips - newser.com
Is Nexalin Technology Inc. stock attractive for retirement portfoliosJuly 2025 EndofMonth & Low Risk Entry Point Tips - newser.com
Will Nexalin Technology Inc. stock deliver better than expected guidanceQuarterly Market Summary & Safe Capital Allocation Plans - newser.com
Should you wait for a breakout in Nexalin Technology Inc.Trade Risk Summary & High Accuracy Trade Alerts - newser.com
How Nexalin Technology Inc. Equity Warrant stock performs in rate cut cyclesPortfolio Performance Summary & Expert Verified Movement Alerts - newser.com
How to monitor Nexalin Technology Inc. Equity Warrant with trend dashboardsJuly 2025 Selloffs & Short-Term High Return Strategies - newser.com
How analysts rate Nexalin Technology Inc. stock today2025 Volatility Report & Long-Term Growth Stock Strategies - newser.com
Will Nexalin Technology Inc. Equity Warrant stock benefit from automationJuly 2025 Highlights & AI Forecast Swing Trade Picks - newser.com
How to monitor Nexalin Technology Inc. with trend dashboardsIndex Update & Reliable Price Breakout Alerts - newser.com
Can Nexalin Technology Inc. stock double in next 5 years2025 Short Interest & Consistent Profit Alerts - newser.com
Nexalin Technology Inc (NXL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Nexalin Technology Inc 주식 (NXL) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Shelton Carolyn Hamby | Sr. VP - Quality, Regulatory |
Mar 12 '25 |
Buy |
2.20 |
6,000 |
13,200 |
30,000 |
| Owens David | Chief Medical Officer |
Feb 04 '25 |
Buy |
3.10 |
1,000 |
3,100 |
155,793 |
| Owens David | Chief Medical Officer |
Feb 04 '25 |
Buy |
2.98 |
1,000 |
2,980 |
154,793 |
| Owens David | Chief Medical Officer |
Jan 28 '25 |
Buy |
2.70 |
1,500 |
4,050 |
153,793 |
| Owens David | Chief Medical Officer |
Jan 13 '25 |
Buy |
2.50 |
2,000 |
5,000 |
151,293 |
| Owens David | Chief Medical Officer |
Jan 23 '25 |
Buy |
2.70 |
1,000 |
2,700 |
152,293 |
1.42%
0.91%
자본화:
|
볼륨(24시간):